JIANG Zhao-shun;ZHAO Jian-qin;LIU Yuan-tao;HAN Chen-dong;QU Wei.
2012, 28(2): 138-142.
Objective To study the effects of sulodexide on renal NF-κB activation and monocyte chemotactic protein 1 (MCP-1) expression in diabetic rats and elucidate the possible mechanism of sulodexide in preventing diabetic nephropathy(DN). Methods Wistar rats were fed with high-sucrose-high-fat diet and injected with a low dose of STZ(streptozotocin,35 mg/kg) into abdominal cavity to induce diabetes. DM rats were randomly divided into non-treated group (DM) and sulodexide treated group(DMS). Normal rats were served as control (NC). After 12 weeks of treatment, blood glucose (BG), triglyceride (TG), cholesterol, serum creatinine (Scr), urea nitrogen (BUN), 24 h urinary albumin excretion (UAE) were measured. HE staining was performed in renal tissues for light microscopy examination of mean glomerular volume (MGV). MCP-1 expression was detected by immunohistochemical method. NF-κB activation was determined by Western blot. Results Compared with NC group, DM group and DMS group had significant elevated BG, TG and TC levels (all P<0.01). There were no significant differences of BG, TG or TC levels between DM group and DMS group. Compared with NC group, DM group and DMS group had significant increased Scr, BUN, UAE levels (all P<0.01). Scr, BUN, UAE levels were significantly lower in DMS group than those in DM group [(39.1±0.88) μmol/L vs (41.0±2.16) μmol/L, (9.12±1.06) mmol/L vs (9.87±0.19) mmol/L; (19.92±0.96) mg/24 h vs (25.99±0.52) mg/24 h, all P<0.05]. Compared with NC group, the MGV of DM group was significantly increased [(7.47±1.11)×105 μm3 vs (4.22±1.09)×105 μm3, P<0.01]. Compared with DM group, the MGA of DMS group was significantly reduced [(6.64±0.71)×105 μm3 vs (7.47±1.11)×105 μm3, P<0.05], but was still increased compared with that of NC group(P<0.01). Compared with NC group, the MCP-1 expression of DM group was significantly higher [(12.17±1.94)/HPF vs (1.19±0.70)/HPF,P<0.01]. MCP-1 expression in DSM group was significantly lower than that of DM group[(9.22±1.61)/HPF vs (12.17±1.94)/HPF, P<0.01], but still higher than that of control group (P<0.01). Compared with NC group, the NF-κB activity was significantly higher in DM group [(0.89±0.07) vs (0.24±0.03), P<0.01]. Compared with DM group, NF-κB activity of DMS group was significantly lower [(0.27±0.01) vs (0.89±0.07), P<0.01]. There was no significant difference of NF-κB activity between DMS group and NC group. Conclusion Sulodexide has protective effects on diabetic nephropathy, and one of the mechanisms may involve the inhibition of NF-κB activation as well as the suppression of MCP-1 expression